Should I prescribe tizanidine 2 mg twice daily (bid) or 4 mg once daily?

Prescribe tizanidine 2 mg twice daily (BID) rather than 4 mg once daily

The FDA-approved dosing strategy for tizanidine explicitly recommends starting at 4 mg with dose repetition at 6-8 hour intervals as needed, supporting a divided dosing approach rather than once-daily administration. 1

Rationale for BID Dosing

Pharmacokinetic Profile Demands Divided Dosing

Tizanidine has a short half-life with effects that peak at 1-2 hours and dissipate between 3-6 hours 1. This pharmacokinetic profile makes once-daily dosing pharmacologically inappropriate, as you would have:

• Therapeutic coverage for only 3-6 hours of a 24-hour period
• Prolonged periods without muscle relaxation or pain control
• Potential for breakthrough spasticity/pain during the 18-21 hours when drug levels are subtherapeutic

FDA Labeling Supports Divided Dosing

The FDA label clearly states: "The dose can be repeated at 6 to 8 hour intervals, as needed, to a maximum of three doses in 24 hours" 1. This guidance inherently supports BID or TID dosing rather than once-daily administration. The label emphasizes that single doses provide effect for "several hours," not 24 hours 1.

Starting Dose Considerations

Begin with 2 mg BID (total 4 mg/day) rather than 4 mg once daily because:

• The FDA recommends starting with 4 mg single doses and titrating gradually in 2-4 mg steps 1
• Adverse effects are dose-dependent, particularly sedation (92% at 16 mg single dose vs 35% at placebo) 1
• Hypotension is dose-related and measured following single doses ≥2 mg 1
• Starting with 2 mg BID provides the same total daily dose but with better tolerability and more consistent coverage

Critical Safety Considerations

Dose-Dependent Risks

• Hypotension: Two-thirds of patients on 8 mg single doses experienced 20% reduction in BP, peaking 2-3 hours post-dose 1
• Sedation: 48% overall sedation rate, with 10% rated as severe; 92% drowsiness at 16 mg single dose 1
• Hepatotoxicity: Monitor LFTs at baseline, 1,3, and 6 months; three deaths from liver failure reported 1

Titration Strategy

1. Start: 2 mg BID (morning and evening)
2. Titrate: Increase by 2-4 mg increments every few days based on response
3. Target: Effective dose typically 12-24 mg/day divided TID 2, 3
4. Maximum: 36 mg/day in divided doses (essentially no experience with single doses >12 mg) 1

Common Pitfalls to Avoid

• Never prescribe 4 mg once daily - this provides inadequate duration of action given the 3-6 hour effect window
• Avoid abrupt discontinuation - risk of withdrawal with rebound tachycardia, hypertension, and hypertonia; taper slowly if discontinuing 4
• Screen for contraindications: Avoid with CYP1A2 inhibitors (ciprofloxacin, fluvoxamine are absolute contraindications; oral contraceptives, cimetidine, famotidine require caution) 4
• Avoid in hepatic/renal dysfunction and elderly due to sedative and hypotensive effects 4

Special Population Considerations

In older adults, tizanidine is preferred over other muscle relaxants as it's not on the 2023 Beers Criteria list (unlike cyclobenzaprine, carisoprodol, etc.) 5. However, start at the lower end (2 mg BID) and monitor closely for sedation and orthostatic hypotension, as older patients rarely tolerate doses >30-40 mg/day 2.